ORIGINAL RESEARCH
Accepted on 03 Sep 2025
Single-Cell Profiling Uncovers PTPRG-Driven Stemness in Malignant Plasma Cells and Signatures of Treatment Failure in Multiple Myeloma
doi 10.3389/fimmu.2025.1658028
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Novel Preclinical Model, Biomarker, Treatment and Drug Delivery to Address Immune Evasion in Cancer: Volume II
Community Series in Novel Preclinical Model, Biomarker, Treatment and Drug Delivery to Address Immune Evasion in Cancer: Volume II
1,710
Total downloads
7,272
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 20 Jun 2025
Case Report: Durable complete response of advanced-stage hepatocellular carcinoma to DEB−TACE combined with lenvatinib and camrelizumab
doi 10.3389/fimmu.2025.1549675
- 1,533 views
ORIGINAL RESEARCH
Published on 28 Mar 2025
Unveiling the power of Treg.Sig: a novel machine-learning derived signature for predicting ICI response in melanoma
doi 10.3389/fimmu.2025.1508638
- 2,114 views
ORIGINAL RESEARCH
Published on 29 Nov 2024
The close association of Muribaculum and PA (10:0/a-17:0) with the occurrence of pancreatic ductal adenocarcinoma and immunotherapy
doi 10.3389/fimmu.2024.1505966
- 1,587 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: